Literature DB >> 14739395

Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier.

Börje Haraldsson1, Jenny Sörensson.   

Abstract

The key question is not why some patients have proteinuria but rather why not all people have it. In the present review, we will present an update on the glomerular barrier after the recent breakthroughs in podocyte biology. In particular, we will discuss the role of the endothelium, which seems to be a neglected part of the glomerular membrane.

Entities:  

Mesh:

Year:  2004        PMID: 14739395     DOI: 10.1152/nips.01461.2003

Source DB:  PubMed          Journal:  News Physiol Sci        ISSN: 0886-1714


  22 in total

1.  Plasma half-life extension of small recombinant antibodies by fusion to immunoglobulin-binding domains.

Authors:  Meike Hutt; Aline Färber-Schwarz; Felix Unverdorben; Fabian Richter; Roland E Kontermann
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  What determines glomerular capillary permeability?

Authors:  William M Deen
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  High glucose causes dysfunction of the human glomerular endothelial glycocalyx.

Authors:  A Singh; V Fridén; I Dasgupta; R R Foster; G I Welsh; J E Tooke; B Haraldsson; P W Mathieson; S C Satchell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-27

4.  Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation.

Authors:  Florian Bolze; Andrea Bast; Sabine Mocek; Volker Morath; Detian Yuan; Nadine Rink; Martin Schlapschy; Anika Zimmermann; Mathias Heikenwalder; Arne Skerra; Martin Klingenspor
Journal:  Diabetologia       Date:  2016-06-07       Impact factor: 10.122

5.  Organic radical contrast agents for magnetic resonance imaging.

Authors:  Andrzej Rajca; Ying Wang; Michael Boska; Joseph T Paletta; Arnon Olankitwanit; Michael A Swanson; Deborah G Mitchell; Sandra S Eaton; Gareth R Eaton; Suchada Rajca
Journal:  J Am Chem Soc       Date:  2012-09-17       Impact factor: 15.419

6.  Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice.

Authors:  M Jeansson; A Björnson Granqvist; J Sörensson Nyström; B Haraldsson
Journal:  Diabetologia       Date:  2006-07-26       Impact factor: 10.122

7.  Podocytes use FcRn to clear IgG from the glomerular basement membrane.

Authors:  Shreeram Akilesh; Tobias B Huber; Hui Wu; Gary Wang; Björn Hartleben; Jeffrey B Kopp; Jeffrey H Miner; Derry C Roopenian; Emil R Unanue; Andrey S Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-15       Impact factor: 11.205

Review 8.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 9.  The role of the glomerular endothelium in albumin handling.

Authors:  Simon Satchell
Journal:  Nat Rev Nephrol       Date:  2013-10-01       Impact factor: 28.314

10.  The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer.

Authors:  Xueyan Dong; Guoqing Wang; Guoqing Zhang; Zhaohui Ni; Jian Suo; Juan Cui; Ai Cui; Qing Yang; Ying Xu; Fan Li
Journal:  Diagn Pathol       Date:  2013-03-19       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.